← FDA Drug Approvals (Drugs@FDA)
TRANYLCYPROMINE SULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CROSSMEDIKA SA · Approved 2022-06-27
Drug application
- FDA Application #
ANDA213503- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRANYLCYPROMINE SULFATE
- Generic name
- TRANYLCYPROMINE
- Active ingredients
- TRANYLCYPROMINE SULFATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CROSSMEDIKA SA
- Manufacturer
- Solco Healthcare US, LLC
- First approval
- 2022-06-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown